Get to know our clinical trials
TO LEARN MORE ABOUT THE BENEFITS AND SAFETY OF TREATMENT WITH AN INVESTIGATIONAL DRUG CALLED BAXDROSTAT IN COMBINATION WITH DAPAGLIFLOZIN IN PATIENTS WITH CKD AND HYPERTENSION AND ALSO TO BETTER UNDERSTAND THE DISEASE STUDIED AND ASSOCIATED HEALTH PROBLEMS.
Status
In recruitment
headquarters
Pamplona/Madrid
Technical Summary
- Code EudraCT: 2023-506457-38
- Protocol number: D6972C00003
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.